Lulu Wang

Institute of Materia Medica, Chinese Academy of Medical Sciences, China

Title: Nano technology facilitate Berberine to ameliorate atherosclerosis through actions against inflammation agitated endothelial dysfunction in High-Fat-diet fed Apoe(-/-) mice

---

Biography

Wang Lulu , 1996 , graduated from Fudan University Shanghai Medical College, 2003 was awarded a Master of Science in Beijing Union Medical College, 2017 was awarded a doctorate in medicine at the Beijing Union Medical College. Since January 1998 , he has worked in the Institute of Pharmaceutical Research. His research interests include research on new drug development, research on targeted drug delivery systems, and research on the mechanism of action of small molecule drugs. In 2008 , he was qualified as an associate researcher in the Ministry of Health. In 2012 , he was appointed as an associate researcher. During his tenure, he hosted and participated in many national, provincial and ministerial research projects and participated in the research and development of a number of drugs. Eight of them have obtained new drug certificates, and published more than forty research papers in domestic and foreign journals. patents 4 items repeatedly reported at international conferences.

Abstract

Targeted drug delivery, tumor targeted therapy, nano drug delivery system, small nucleic acid treatment and delivery